Wake-promoting Agents

Wake-Promoting Agents is a class of pharmacological compounds that, as a genus, enhance central nervous system arousal, and, as distinguished by their specific mechanism of action, selectively target neurochemical pathways to promote sustained wakefulness in individuals with hypersomnolence disorders.

98

Publications

7K

Citations

586

Authors

197

Institutions

Publications per year

2017–2026

26

Variants

Wake-promoting DrugsWake-promoting Medications

Authors

586

  1. JA
    John A. Gruner

    Brandywine Photonics (United States), United States

    9 publications · 247 citations

    9

    h-index

  2. LD
    Lisa D. Aimone

    Avalon Pharma (United States), United States

    7 publications · 158 citations

    7

    h-index

  3. JR
    Joanne R. Mathiasen

    Springhouse, United States

    7 publications · 189 citations

    7

    h-index

  4. RR
    Rita Raddatz

    Medical University of South Carolina, United States

    5 publications · 106 citations

    5

    h-index

  5. RL
    Robert L. Hudkins

    Brandywine Photonics (United States), United States

    5 publications · 106 citations

    5

    h-index

1–5 of 586

Venues

  1. SLEEP

    10 publications · 723 citations

    10

    h-index

  2. 6

    h-index

  3. Pharmacology Biochemistry and Behavior

    4 publications · 430 citations

    4

    h-index

  4. Bioorganic & Medicinal Chemistry Letters

    4 publications · 55 citations

    4

    h-index

  5. Journal of Neuroscience

    3 publications · 1K citations

    3

    h-index

1–5